Menopause isn’t a footnote in women’s health—it’s a turning point that shapes brain, heart, and bone outcomes for decades. We sit down with Dr. Betty Murray to unpack why 87% of women face significant symptoms for an average of eight years, how a single misread study sidelined hormone therapy for a generation, and what it takes to move from guesswork to guardrails using bioidentical hormones, labs, and wearable data. The conversation is candid, data-rich, and focused on practical change: restoring sleep, improving mood and cognition, reducing fracture risk, and protecting long-term vitality with individualized care.

We walk through the vision for Minerva, a women’s health platform that unifies symptom tracking, lab ordering, and device data into one simple workflow—then adds telemedicine and a dosing framework built on twenty years of clinical experience. Instead of chasing hot flashes alone, the approach targets protective benefits, recognizing that many women are underdosed for the brain, heart, and bones even when night sweats fade. We also talk timing, delivery routes, and hormone metabolism—why personalized pathways matter if you want real outcomes, not just temporary relief.

There’s a hard look at insurance gaps and the long shadow of research that excluded women for far too long. With 57,000 survey responses and a rapidly growing community, the team is building a flywheel for discovery—turning real-world care into better evidence for PMDD, PCOS, autoimmunity, osteoporosis, and cognitive health. If you care about smarter menopause care, tech that actually simplifies life, and a future where women aren’t left out of the data, this conversation is for you.

If this resonates, follow along, share the episode with someone who needs it, and leave a quick review so more women can find it. Your feedback helps shape what we build next.